{"resourceType":"Measure","id":"EXM145v11QICore4","meta":{"versionId":"1","lastUpdated":"2022-08-14T09:30:08.000-06:00","source":"#RTu1vy87As62T83s","profile":["http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-measure-cqfm"]},"language":"en","contained":[{"resourceType":"Library","id":"effective-data-requirements","extension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode","valueCoding":{"system":"http://terminology.hl7.org/CodeSystem/condition-clinical","code":"active"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode","valueCoding":{"system":"http://terminology.hl7.org/CodeSystem/condition-ver-status","code":"confirmed"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode","valueCoding":{"system":"http://snomed.info/sct","code":"134401001","display":"Left ventricular systolic dysfunction (disorder)"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode","valueCoding":{"system":"http://snomed.info/sct","code":"373254001","display":"Substance with beta adrenergic receptor antagonist mechanism of action (substance)"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode","valueCoding":{"system":"http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical","code":"active"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode","valueCoding":{"system":"http://terminology.hl7.org/CodeSystem/allergyintolerance-verification","code":"confirmed"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"SupplementalDataElementsQICore4"},{"url":"name","valueString":"SDE Sex"},{"url":"statement","valueString":"define \"SDE Sex\":\n  case\n      when Patient.gender = 'male' then Code { code: 'M', system: 'http://hl7.org/fhir/v3/AdministrativeGender', display: 'Male' }\n      when Patient.gender = 'female' then Code { code: 'F', system: 'http://hl7.org/fhir/v3/AdministrativeGender', display: 'Female' }\n      else null\n    end"},{"url":"displaySequence","valueInteger":0}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"SDE Sex"},{"url":"statement","valueString":"define \"SDE Sex\":\n  SDE.\"SDE Sex\""},{"url":"displaySequence","valueInteger":1}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"AHAOverallQICore4"},{"url":"name","valueString":"Qualifying Encounter During Measurement Period"},{"url":"statement","valueString":"define \"Qualifying Encounter During Measurement Period\":\n  ( [\"Encounter\": \"Care Services in Long Term Residential Facility\"]\n    union [\"Encounter\": \"Home Healthcare Services\"]\n    union [\"Encounter\": \"Nursing Facility Visit\"]\n    union [\"Encounter\": \"Office Visit\"]\n    union [\"Encounter\": \"Outpatient Consultation\"]\n    union [\"Encounter\": \"Patient Provider Interaction\"] ) ValidEncounter\n    where ValidEncounter.period during \"Measurement Period\"\n      and ValidEncounter.isFinished()"},{"url":"displaySequence","valueInteger":2}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Coronary Artery Disease Encounter"},{"url":"statement","valueString":"define \"Coronary Artery Disease Encounter\":\n   AHA.\"Qualifying Encounter During Measurement Period\"  QualifyingEncounter\n    with [\"Condition\": \"Coronary Artery Disease No MI\"] CoronaryArteryDisease\n      such that CoronaryArteryDisease.toPrevalenceInterval() overlaps QualifyingEncounter.period\n        and CoronaryArteryDisease.isConfirmedActiveDiagnosis()"},{"url":"displaySequence","valueInteger":3}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"History of Cardiac Surgery"},{"url":"statement","valueString":"define \"History of Cardiac Surgery\":\n  AHA.\"Qualifying Encounter During Measurement Period\" QualifyingEncounter\n    with [\"Procedure\": \"Cardiac Surgery\"] CardiacSurgery\n        such that CardiacSurgery.performed.toInterval() starts before end of QualifyingEncounter.period\n          and CardiacSurgery.isCompleted()"},{"url":"displaySequence","valueInteger":4}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Qualifying CAD Encounter"},{"url":"statement","valueString":"define \"Qualifying CAD Encounter\":\n  \"Coronary Artery Disease Encounter\"\n    union \"History of Cardiac Surgery\""},{"url":"displaySequence","valueInteger":5}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Initial Population"},{"url":"statement","valueString":"define \"Initial Population\":\n  //curent problem with AgeInYearsAt required a modified approach - refer to https://github.com/cqframework/ecqm-content-qicore-2022/issues/6\n  CalculateAgeInYearsAt(Patient.birthDate, date from start of \"Measurement Period\") >= 18 \n    and Count (AHA.\"Qualifying Encounter During Measurement Period\")>= 2\n    and exists ( \"Qualifying CAD Encounter\" )"},{"url":"displaySequence","valueInteger":6}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"AHAOverallQICore4"},{"url":"name","valueString":"Moderate or Severe LVSD Observations"},{"url":"statement","valueString":"define \"Moderate or Severe LVSD Observations\":\n  [\"Observation\": \"Ejection Fraction\"] EjectionFraction\n    where EjectionFraction.value <= 40 '%'\n      and EjectionFraction.status in {'final', 'amended', 'corrected'}"},{"url":"displaySequence","valueInteger":7}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"AHAOverallQICore4"},{"url":"name","valueString":"Moderate or Severe LVSD Conditions"},{"url":"statement","valueString":"define \"Moderate or Severe LVSD Conditions\":\n  ( [\"Condition\": \"Moderate or Severe LVSD\"]\n      union ( [\"Condition\": \"Left ventricular systolic dysfunction (disorder)\"] LeftVentricular\n                where LeftVentricular.severity in \"Moderate or Severe\"\n              )\n    ) LVSD\n    where LVSD.isConfirmedActiveDiagnosis()"},{"url":"displaySequence","valueInteger":8}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Qualifying CAD Encounter and Prior MI"},{"url":"statement","valueString":"define \"Qualifying CAD Encounter and Prior MI\":\n  \"Qualifying CAD Encounter\" EncounterWithCADProxy\n    with [\"Condition\": \"Myocardial Infarction\"] MyocardialInfarction\n      such that MyocardialInfarction.toPrevalenceInterval() starts 3 years or less before day of start of EncounterWithCADProxy.period\n        and MyocardialInfarction.isConfirmedActiveDiagnosis()\n    where not ( exists ( AHA.\"Moderate or Severe LVSD Observations\" )\n      or exists (AHA.\"Moderate or Severe LVSD Conditions\") )"},{"url":"displaySequence","valueInteger":9}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Denominator 2"},{"url":"statement","valueString":"define \"Denominator 2\":\n  \"Initial Population\"\n    and exists \"Qualifying CAD Encounter and Prior MI\""},{"url":"displaySequence","valueInteger":10}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Qualifying CAD Encounter and History of Moderate or Severe LVSD"},{"url":"statement","valueString":"define \"Qualifying CAD Encounter and History of Moderate or Severe LVSD\":\n  ( \"Qualifying CAD Encounter\" EncounterWithCADProxy\n      with AHA.\"Moderate or Severe LVSD Observations\" LVSDObservations\n        such that LVSDObservations.effective.toInterval() starts before end of EncounterWithCADProxy.period \n    )\n  union \n  ( \"Qualifying CAD Encounter\" EncounterWithCADProxy\n      with AHA.\"Moderate or Severe LVSD Conditions\" LVSDObservations\n        such that LVSDObservations.toPrevalenceInterval() starts before end of EncounterWithCADProxy.period \n    )"},{"url":"displaySequence","valueInteger":11}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Arrhythmia with Qualifying CAD Encounter and History of Moderate or Severe LVSD"},{"url":"statement","valueString":"define \"Has Arrhythmia with Qualifying CAD Encounter and History of Moderate or Severe LVSD\":\n  exists ( \n            [\"Condition\": \"Arrhythmia\"] Arrhythmia\n              where Arrhythmia.overlapsEncounter(\"Qualifying CAD Encounter and History of Moderate or Severe LVSD\")\n          )"},{"url":"displaySequence","valueInteger":12}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Asthma with Qualifying CAD Encounter and History of Moderate or Severe LVSD"},{"url":"statement","valueString":"define \"Has Asthma with Qualifying CAD Encounter and History of Moderate or Severe LVSD\":\n  exists ( \n            [\"Condition\": \"Asthma\"] Asthma\n              where Asthma.overlapsEncounter(\"Qualifying CAD Encounter and History of Moderate or Severe LVSD\")\n          )"},{"url":"displaySequence","valueInteger":13}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Bradycardia with Qualifying CAD Encounter and History of Moderate or Severe LVSD"},{"url":"statement","valueString":"define \"Has Bradycardia with Qualifying CAD Encounter and History of Moderate or Severe LVSD\":\n  exists ( \n            [\"Condition\": \"Bradycardia\"] Bradycardia\n              with \"Qualifying CAD Encounter and History of Moderate or Severe LVSD\" CADEncounterModerateOrSevereLVSD\n                such that Bradycardia.toPrevalenceInterval() overlaps CADEncounterModerateOrSevereLVSD.period\n              where Bradycardia.isConfirmedActiveDiagnosis()\n          )"},{"url":"displaySequence","valueInteger":14}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Hypotension with Qualifying CAD Encounter and History of Moderate or Severe LVSD"},{"url":"statement","valueString":"define \"Has Hypotension with Qualifying CAD Encounter and History of Moderate or Severe LVSD\":\n  exists ( \n            [\"Condition\": \"Hypotension\"] Hypotension\n              where Hypotension.overlapsAfterEncounter(\"Qualifying CAD Encounter and History of Moderate or Severe LVSD\")\n          )"},{"url":"displaySequence","valueInteger":15}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Consecutive Heart Rates Less than 50 with Qualifying CAD Encounter and History of Moderate or Severe LVSD"},{"url":"statement","valueString":"define \"Has Consecutive Heart Rates Less than 50 with Qualifying CAD Encounter and History of Moderate or Severe LVSD\":\n  \"Has Consecutive Heart Rates Less than 50 with Qualifying CAD Encounter\"(\"Qualifying CAD Encounter and History of Moderate or Severe LVSD\")"},{"url":"displaySequence","valueInteger":16}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Allergy or Intolerance to Beta Blocker Therapy Ingredient with Qualifying CAD Encounter and History of Moderate or Severe LVSD"},{"url":"statement","valueString":"define \"Has Allergy or Intolerance to Beta Blocker Therapy Ingredient with Qualifying CAD Encounter and History of Moderate or Severe LVSD\":\n  exists ( ( [\"AllergyIntolerance\": \"Beta Blocker Therapy Ingredient\"]\n            union [\"AllergyIntolerance\": \"Substance with beta adrenergic receptor antagonist mechanism of action (substance)\"] ) BetaBlockerAllergyIntolerance\n            where BetaBlockerAllergyIntolerance.isActiveAllergyBeforeOrDuringEncounter(\"Qualifying CAD Encounter and History of Moderate or Severe LVSD\")\n         )"},{"url":"displaySequence","valueInteger":17}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Diagnosis of Allergy or Intolerance to Beta Blocker Therapy with Qualifying CAD Encounter and History of Moderate or Severe LVSD"},{"url":"statement","valueString":"define \"Has Diagnosis of Allergy or Intolerance to Beta Blocker Therapy with Qualifying CAD Encounter and History of Moderate or Severe LVSD\":\n  exists ( \n            ( [\"Condition\": \"Allergy to Beta Blocker Therapy\"]\n              union [\"Condition\": \"Intolerance to Beta Blocker Therapy\"] ) BetaBlockerAllergyOrIntoleranceDiagnosis\n                where BetaBlockerAllergyOrIntoleranceDiagnosis.overlapsAfterEncounter(\"Qualifying CAD Encounter and History of Moderate or Severe LVSD\")\n          )"},{"url":"displaySequence","valueInteger":18}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Medical Patient or System Reason for Not Ordering Beta Blocker for LVSD"},{"url":"statement","valueString":"/*This definition currently throws an error when evaluated in VS Code \nrefer to https://github.com/cqframework/vscode-cql/issues/14 */\ndefine \"Has Medical Patient or System Reason for Not Ordering Beta Blocker for LVSD\":\n  exists ( \n            [\"MedicationNotRequested\"] NoBetaBlockerOrdered\n            //currently no primary code path in model info for MedicationNotRequested\n            //refer to https://github.com/cqframework/clinical_quality_language/issues/789\n              where NoBetaBlockerOrdered.medication in \"Beta Blocker Therapy for LVSD\" \n                and NoBetaBlockerOrdered.isNotOrderedDuringEncounter(\"Qualifying CAD Encounter and History of Moderate or Severe LVSD\")\n          )"},{"url":"displaySequence","valueInteger":19}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Atrioventricular Block with Qualifying CAD Encounter and History of Moderate or Severe LVSD"},{"url":"statement","valueString":"define \"Has Atrioventricular Block with Qualifying CAD Encounter and History of Moderate or Severe LVSD\":\n  exists ( \n            [\"Condition\": \"Atrioventricular Block\"] AtrioventricularBlock\n              where AtrioventricularBlock.overlapsEncounter(\"Qualifying CAD Encounter and History of Moderate or Severe LVSD\")\n          )"},{"url":"displaySequence","valueInteger":20}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Diagnosis of Cardiac Pacer in Situ with Qualifying CAD Encounter and History of Moderate or Severe LVSD"},{"url":"statement","valueString":"define \"Has Diagnosis of Cardiac Pacer in Situ with Qualifying CAD Encounter and History of Moderate or Severe LVSD\":\n  exists ( \n            [\"Condition\": \"Cardiac Pacer in Situ\"] CardiacPacerDiagnosis\n              where CardiacPacerDiagnosis.overlapsAfterEncounter(\"Qualifying CAD Encounter and History of Moderate or Severe LVSD\")\n          )"},{"url":"displaySequence","valueInteger":21}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Cardiac Pacer Device Implanted with Qualifying CAD Encounter and History of Moderate or Severe LVSD"},{"url":"statement","valueString":"define \"Has Cardiac Pacer Device Implanted with Qualifying CAD Encounter and History of Moderate or Severe LVSD\":\n  exists ( [\"Procedure\": \"Cardiac Pacer\"] ImplantedCardiacPacer\n            with \"Qualifying CAD Encounter and History of Moderate or Severe LVSD\" CADEncounterModerateOrSevereLVSD\n              such that ImplantedCardiacPacer.performed.toInterval() overlaps after CADEncounterModerateOrSevereLVSD.period\n                or ImplantedCardiacPacer.performed.toInterval() before end of CADEncounterModerateOrSevereLVSD.period\n            where ImplantedCardiacPacer.isCompleted()\n          )"},{"url":"displaySequence","valueInteger":22}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Atrioventricular Block with Qualifying CAD Encounter and History of Moderate or Severe LVSD without Cardiac Pacer"},{"url":"statement","valueString":"define \"Has Atrioventricular Block with Qualifying CAD Encounter and History of Moderate or Severe LVSD without Cardiac Pacer\":\n  \"Has Atrioventricular Block with Qualifying CAD Encounter and History of Moderate or Severe LVSD\"\n    and not \"Has Diagnosis of Cardiac Pacer in Situ with Qualifying CAD Encounter and History of Moderate or Severe LVSD\"\n    and not \"Has Cardiac Pacer Device Implanted with Qualifying CAD Encounter and History of Moderate or Severe LVSD\""},{"url":"displaySequence","valueInteger":23}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Denominator Exceptions 1"},{"url":"statement","valueString":"define \"Denominator Exceptions 1\":\n  \"Has Arrhythmia with Qualifying CAD Encounter and History of Moderate or Severe LVSD\"\n    or \"Has Asthma with Qualifying CAD Encounter and History of Moderate or Severe LVSD\"\n    or \"Has Bradycardia with Qualifying CAD Encounter and History of Moderate or Severe LVSD\"\n    or \"Has Hypotension with Qualifying CAD Encounter and History of Moderate or Severe LVSD\"\n    or \"Has Consecutive Heart Rates Less than 50 with Qualifying CAD Encounter and History of Moderate or Severe LVSD\"\n    or \"Has Allergy or Intolerance to Beta Blocker Therapy Ingredient with Qualifying CAD Encounter and History of Moderate or Severe LVSD\"\n    or \"Has Diagnosis of Allergy or Intolerance to Beta Blocker Therapy with Qualifying CAD Encounter and History of Moderate or Severe LVSD\"\n    or \"Has Medical Patient or System Reason for Not Ordering Beta Blocker for LVSD\"\n    or \"Has Atrioventricular Block with Qualifying CAD Encounter and History of Moderate or Severe LVSD without Cardiac Pacer\""},{"url":"displaySequence","valueInteger":24}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Beta Blocker Therapy for LVSD Ordered"},{"url":"statement","valueString":"define \"Has Beta Blocker Therapy for LVSD Ordered\":\n  exists ( \n            [\"MedicationRequest\": \"Beta Blocker Therapy for LVSD\"] BetaBlockerForLVSDOrdered\n              with \"Qualifying CAD Encounter and History of Moderate or Severe LVSD\" CADEncounterModerateOrSevereLVSD\n                such that BetaBlockerForLVSDOrdered.authoredOn during CADEncounterModerateOrSevereLVSD.period\n              where BetaBlockerForLVSDOrdered.status in {'active', 'completed'}\n                and BetaBlockerForLVSDOrdered.intent = 'order'\n            )"},{"url":"displaySequence","valueInteger":25}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Is Currently Taking Beta Blocker Therapy for LVSD"},{"url":"statement","valueString":"define \"Is Currently Taking Beta Blocker Therapy for LVSD\":\n  exists ( \n            [\"MedicationRequest\": \"Beta Blocker Therapy for LVSD\"] ActiveBetaBlockerForLVSD\n              with \"Qualifying CAD Encounter and History of Moderate or Severe LVSD\" CADEncounterModerateOrSevereLVSD\n                such that exists(ActiveBetaBlockerForLVSD.dosageInstruction.timing T\n                                  where T.repeat.bounds.toInterval() overlaps after CADEncounterModerateOrSevereLVSD.period )\n              where ActiveBetaBlockerForLVSD.status in { 'active', 'completed', 'finished' }            \n          )"},{"url":"displaySequence","valueInteger":26}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Numerator 1"},{"url":"statement","valueString":"define \"Numerator 1\":\n  \"Has Beta Blocker Therapy for LVSD Ordered\"\n    or \"Is Currently Taking Beta Blocker Therapy for LVSD\""},{"url":"displaySequence","valueInteger":27}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"SupplementalDataElementsQICore4"},{"url":"name","valueString":"SDE Payer"},{"url":"statement","valueString":"define \"SDE Payer\":\n  [Coverage: type in \"Payer\"] Payer\n    return {\n      code: Payer.type,\n      period: Payer.period\n    }"},{"url":"displaySequence","valueInteger":28}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"SDE Payer"},{"url":"statement","valueString":"define \"SDE Payer\":\n  SDE.\"SDE Payer\""},{"url":"displaySequence","valueInteger":29}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Beta Blocker Therapy Ordered"},{"url":"statement","valueString":"define \"Has Beta Blocker Therapy Ordered\":\n  exists ( \n            [\"MedicationRequest\": \"Beta Blocker Therapy\"] BetaBlockerOrdered\n              with \"Qualifying CAD Encounter and Prior MI\" CADEncounterMI\n                such that BetaBlockerOrdered.authoredOn during CADEncounterMI.period\n              where BetaBlockerOrdered.status in {'active', 'completed'}\n                  and BetaBlockerOrdered.intent = 'order'\n             )"},{"url":"displaySequence","valueInteger":30}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Is Currently Taking Beta Blocker Therapy"},{"url":"statement","valueString":"define \"Is Currently Taking Beta Blocker Therapy\":\n  exists ( \n            [\"MedicationRequest\": \"Beta Blocker Therapy\"] ActiveBetaBlocker\n              with \"Qualifying CAD Encounter and Prior MI\" CADEncounterMI\n              such that exists(ActiveBetaBlocker.dosageInstruction.timing T\n                                  where T.repeat.bounds.toInterval() overlaps after CADEncounterMI.period )\n              where ActiveBetaBlocker.status in { 'active', 'completed', 'finished' }            \n                )"},{"url":"displaySequence","valueInteger":31}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Numerator 2"},{"url":"statement","valueString":"define \"Numerator 2\":\n  \"Has Beta Blocker Therapy Ordered\"\n    or \"Is Currently Taking Beta Blocker Therapy\""},{"url":"displaySequence","valueInteger":32}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"SupplementalDataElementsQICore4"},{"url":"name","valueString":"SDE Ethnicity"},{"url":"statement","valueString":"define \"SDE Ethnicity\":\n  Patient.ethnicity E\n    return Tuple {\n      codes: { E.ombCategory } union E.detailed,\n      display: E.text\n    }"},{"url":"displaySequence","valueInteger":33}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"SDE Ethnicity"},{"url":"statement","valueString":"define \"SDE Ethnicity\":\n  SDE.\"SDE Ethnicity\""},{"url":"displaySequence","valueInteger":34}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Arrhythmia with Qualifying CAD Encounter and Prior MI"},{"url":"statement","valueString":"define \"Has Arrhythmia with Qualifying CAD Encounter and Prior MI\":\n  exists ( \n            [\"Condition\": \"Arrhythmia\"] Arrhythmia\n              where Arrhythmia.overlapsEncounter(\"Qualifying CAD Encounter and Prior MI\")\n          )"},{"url":"displaySequence","valueInteger":35}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Asthma with Qualifying CAD Encounter and Prior MI"},{"url":"statement","valueString":"define \"Has Asthma with Qualifying CAD Encounter and Prior MI\":\n  exists ( \n            [\"Condition\": \"Asthma\"] Asthma\n              where Asthma.overlapsEncounter(\"Qualifying CAD Encounter and Prior MI\")\n          )"},{"url":"displaySequence","valueInteger":36}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Bradycardia with Qualifying CAD Encounter and Prior MI"},{"url":"statement","valueString":"define \"Has Bradycardia with Qualifying CAD Encounter and Prior MI\":\n  exists ( \n            [\"Condition\": \"Bradycardia\"] Bradycardia\n              with \"Qualifying CAD Encounter and Prior MI\" CADEncounterMI\n                such that Bradycardia.toPrevalenceInterval() overlaps CADEncounterMI.period\n              where Bradycardia.isConfirmedActiveDiagnosis()\n          )"},{"url":"displaySequence","valueInteger":37}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Hypotension with Qualifying CAD Encounter and Prior MI"},{"url":"statement","valueString":"define \"Has Hypotension with Qualifying CAD Encounter and Prior MI\":\n  exists ( \n            [\"Condition\": \"Hypotension\"] Hypotension\n              where Hypotension.overlapsAfterEncounter(\"Qualifying CAD Encounter and Prior MI\")\n          )"},{"url":"displaySequence","valueInteger":38}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Consecutive Heart Rates Less than 50 with Qualifying CAD Encounter and Prior MI"},{"url":"statement","valueString":"define \"Has Consecutive Heart Rates Less than 50 with Qualifying CAD Encounter and Prior MI\":\n  \"Has Consecutive Heart Rates Less than 50 with Qualifying CAD Encounter\"(\"Qualifying CAD Encounter and Prior MI\")"},{"url":"displaySequence","valueInteger":39}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Allergy or Intolerance to Beta Blocker Therapy Ingredient with Qualifying CAD Encounter and Prior MI"},{"url":"statement","valueString":"define \"Has Allergy or Intolerance to Beta Blocker Therapy Ingredient with Qualifying CAD Encounter and Prior MI\":\n  exists ( \n          ( [\"AllergyIntolerance\": \"Beta Blocker Therapy Ingredient\"]\n              union [\"AllergyIntolerance\": \"Substance with beta adrenergic receptor antagonist mechanism of action (substance)\"] ) BetaBlockerAllergyIntolerance\n            where BetaBlockerAllergyIntolerance.isActiveAllergyBeforeOrDuringEncounter( \"Qualifying CAD Encounter and Prior MI\" )\n          )"},{"url":"displaySequence","valueInteger":40}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Diagnosis of Allergy or Intolerance to Beta Blocker Therapy with Qualifying CAD Encounter and Prior MI"},{"url":"statement","valueString":"define \"Has Diagnosis of Allergy or Intolerance to Beta Blocker Therapy with Qualifying CAD Encounter and Prior MI\":\n  exists ( \n            ( [\"Condition\": \"Allergy to Beta Blocker Therapy\"]\n                union [\"Condition\": \"Intolerance to Beta Blocker Therapy\"] ) BetaBlockerAllergyOrIntoleranceDiagnosis\n              where BetaBlockerAllergyOrIntoleranceDiagnosis.overlapsAfterEncounter(\"Qualifying CAD Encounter and Prior MI\")\n       )"},{"url":"displaySequence","valueInteger":41}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Medical Patient or System Reason for Not Ordering Beta Blocker Therapy"},{"url":"statement","valueString":"/*This definition currently throws an error when evaluated in VS Code \nrefer to https://github.com/cqframework/vscode-cql/issues/14 */\ndefine \"Has Medical Patient or System Reason for Not Ordering Beta Blocker Therapy\":\n  exists ( \n            [\"MedicationNotRequested\"] NoBetaBlockerOrdered\n            //currently no primary code path in model info for MedicationNotRequested\n            //refer to https://github.com/cqframework/clinical_quality_language/issues/789\n              where NoBetaBlockerOrdered.medication in \"Beta Blocker Therapy\" \n                and NoBetaBlockerOrdered.isNotOrderedDuringEncounter(\"Qualifying CAD Encounter and Prior MI\") \n          )"},{"url":"displaySequence","valueInteger":42}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Atrioventricular Block with Qualifying CAD Encounter and Prior MI"},{"url":"statement","valueString":"define \"Has Atrioventricular Block with Qualifying CAD Encounter and Prior MI\":\n  exists ( \n            [\"Condition\": \"Atrioventricular Block\"] AtrioventricularBlock\n              where AtrioventricularBlock.overlapsEncounter(\"Qualifying CAD Encounter and Prior MI\") \n          )"},{"url":"displaySequence","valueInteger":43}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Diagnosis of Cardiac Pacer in Situ with Qualifying CAD Encounter and Prior MI"},{"url":"statement","valueString":"define \"Has Diagnosis of Cardiac Pacer in Situ with Qualifying CAD Encounter and Prior MI\":\n  exists ( \n            [\"Condition\": \"Cardiac Pacer in Situ\"] CardiacPacerDiagnosis\n              where CardiacPacerDiagnosis.overlapsAfterEncounter(\"Qualifying CAD Encounter and Prior MI\")\n          )"},{"url":"displaySequence","valueInteger":44}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Cardiac Pacer Device Implanted with Qualifying CAD Encounter and Prior MI"},{"url":"statement","valueString":"define \"Has Cardiac Pacer Device Implanted with Qualifying CAD Encounter and Prior MI\":\n  exists ( \n            [\"Procedure\": \"Cardiac Pacer\"] ImplantedCardiacPacer\n              with \"Qualifying CAD Encounter and Prior MI\" CADEncounterMI\n                such that ImplantedCardiacPacer.performed.toInterval() overlaps after CADEncounterMI.period\n                  or ImplantedCardiacPacer.performed.toInterval() before end of CADEncounterMI.period\n              where ImplantedCardiacPacer.isCompleted()\n     )"},{"url":"displaySequence","valueInteger":45}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Has Atrioventricular Block with Qualifying CAD Encounter and Prior MI without Cardiac Pacer"},{"url":"statement","valueString":"define \"Has Atrioventricular Block with Qualifying CAD Encounter and Prior MI without Cardiac Pacer\":\n  \"Has Atrioventricular Block with Qualifying CAD Encounter and Prior MI\"\n    and not \"Has Diagnosis of Cardiac Pacer in Situ with Qualifying CAD Encounter and Prior MI\"\n    and not \"Has Cardiac Pacer Device Implanted with Qualifying CAD Encounter and Prior MI\""},{"url":"displaySequence","valueInteger":46}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Denominator Exceptions 2"},{"url":"statement","valueString":"define \"Denominator Exceptions 2\":\n  \"Has Arrhythmia with Qualifying CAD Encounter and Prior MI\"\n    or \"Has Asthma with Qualifying CAD Encounter and Prior MI\"\n    or \"Has Bradycardia with Qualifying CAD Encounter and Prior MI\"\n    or \"Has Hypotension with Qualifying CAD Encounter and Prior MI\"\n    or \"Has Consecutive Heart Rates Less than 50 with Qualifying CAD Encounter and Prior MI\"\n    or \"Has Allergy or Intolerance to Beta Blocker Therapy Ingredient with Qualifying CAD Encounter and Prior MI\"\n    or \"Has Diagnosis of Allergy or Intolerance to Beta Blocker Therapy with Qualifying CAD Encounter and Prior MI\"\n    or \"Has Medical Patient or System Reason for Not Ordering Beta Blocker Therapy\"\n    or \"Has Atrioventricular Block with Qualifying CAD Encounter and Prior MI without Cardiac Pacer\""},{"url":"displaySequence","valueInteger":47}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"SupplementalDataElementsQICore4"},{"url":"name","valueString":"SDE Race"},{"url":"statement","valueString":"define \"SDE Race\":\n  Patient.race R\n    return Tuple {\n      codes: R.ombCategory union R.detailed,\n      display: R.text\n    }"},{"url":"displaySequence","valueInteger":48}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"SDE Race"},{"url":"statement","valueString":"define \"SDE Race\":\n  SDE.\"SDE Race\""},{"url":"displaySequence","valueInteger":49}]},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition","extension":[{"url":"libraryName","valueString":"EXM145v11QICore4"},{"url":"name","valueString":"Denominator 1"},{"url":"statement","valueString":"define \"Denominator 1\":   \n  \"Initial Population\"\n    and exists \"Qualifying CAD Encounter and History of Moderate or Severe LVSD\""},{"url":"displaySequence","valueInteger":50}]}],"status":"active","type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/library-type","code":"module-definition"}]},"relatedArtifact":[{"type":"depends-on","display":"Library SDE","resource":"http://ecqi.healthit.gov/ecqms/Library/SupplementalDataElementsQICore4|3.0.000"},{"type":"depends-on","display":"Library AHA","resource":"http://ecqi.healthit.gov/ecqms/Library/AHAOverallQICore4|1.0.000"},{"type":"depends-on","display":"Library FHIRHelpers","resource":"http://ecqi.healthit.gov/ecqms/Library/FHIRHelpers|4.1.000"},{"type":"depends-on","display":"Library Common","resource":"http://ecqi.healthit.gov/ecqms/Library/QICoreCommon|1.2.000"},{"type":"depends-on","display":"Code system ConditionClinicalStatusCodes","resource":"http://terminology.hl7.org/CodeSystem/condition-clinical"},{"type":"depends-on","display":"Code system ConditionVerificationStatusCodes","resource":"http://terminology.hl7.org/CodeSystem/condition-ver-status"},{"type":"depends-on","display":"Code system SNOMEDCT","resource":"http://snomed.info/sct"},{"type":"depends-on","display":"Code system AllergyIntoleranceClinicalStatusCodes","resource":"http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical"},{"type":"depends-on","display":"Code system AllergyIntoleranceVerificationStatusCodes","resource":"http://terminology.hl7.org/CodeSystem/allergyintolerance-verification"},{"type":"depends-on","display":"Value set Care Services in Long Term Residential Facility","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1014"},{"type":"depends-on","display":"Value set Home Healthcare Services","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1016"},{"type":"depends-on","display":"Value set Nursing Facility Visit","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1012"},{"type":"depends-on","display":"Value set Office Visit","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001"},{"type":"depends-on","display":"Value set Outpatient Consultation","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1008"},{"type":"depends-on","display":"Value set Patient Provider Interaction","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1012"},{"type":"depends-on","display":"Value set Coronary Artery Disease No MI","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.369"},{"type":"depends-on","display":"Value set Cardiac Surgery","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.371"},{"type":"depends-on","display":"Value set Myocardial Infarction","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.403"},{"type":"depends-on","display":"Value set Ejection Fraction","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1134"},{"type":"depends-on","display":"Value set Moderate or Severe LVSD","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1090"},{"type":"depends-on","display":"Value set Moderate or Severe","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1092"},{"type":"depends-on","display":"Value set Arrhythmia","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.366"},{"type":"depends-on","display":"Value set Asthma","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.362"},{"type":"depends-on","display":"Value set Bradycardia","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.412"},{"type":"depends-on","display":"Value set Hypotension","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.370"},{"type":"depends-on","display":"Value set Beta Blocker Therapy Ingredient","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1493"},{"type":"depends-on","display":"Value set Allergy to Beta Blocker Therapy","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1177"},{"type":"depends-on","display":"Value set Intolerance to Beta Blocker Therapy","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1178"},{"type":"depends-on","display":"Value set Beta Blocker Therapy for LVSD","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1184"},{"type":"depends-on","display":"Value set Medical Reason","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1007"},{"type":"depends-on","display":"Value set Patient Reason","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1008"},{"type":"depends-on","display":"Value set System Reason","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1009"},{"type":"depends-on","display":"Value set Atrioventricular Block","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.367"},{"type":"depends-on","display":"Value set Cardiac Pacer in Situ","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.368"},{"type":"depends-on","display":"Value set Cardiac Pacer","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.53"},{"type":"depends-on","display":"Value set Payer","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591"},{"type":"depends-on","display":"Value set Beta Blocker Therapy","resource":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1174"}],"parameter":[{"name":"Measurement Period","use":"in","min":0,"max":"1","type":"Period"},{"name":"SDE Sex","use":"out","min":0,"max":"1","type":"Coding"},{"name":"Denominator 2","use":"out","min":0,"max":"1","type":"boolean"},{"name":"Denominator Exceptions 1","use":"out","min":0,"max":"1","type":"boolean"},{"name":"Numerator 1","use":"out","min":0,"max":"1","type":"boolean"},{"name":"SDE Payer","use":"out","min":0,"max":"*","type":"Any"},{"name":"Numerator 2","use":"out","min":0,"max":"1","type":"boolean"},{"name":"Initial Population","use":"out","min":0,"max":"1","type":"boolean"},{"name":"SDE Ethnicity","use":"out","min":0,"max":"1","type":"Any"},{"name":"Denominator Exceptions 2","use":"out","min":0,"max":"1","type":"boolean"},{"name":"SDE Race","use":"out","min":0,"max":"1","type":"Any"},{"name":"Denominator 1","use":"out","min":0,"max":"1","type":"boolean"}],"dataRequirement":[{"type":"Patient","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"]},{"type":"Patient","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"],"mustSupport":["url","extension"],"codeFilter":[{"path":"url","code":[{"code":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity"}]}]},{"type":"Patient","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"],"mustSupport":["url","extension"],"codeFilter":[{"path":"url","code":[{"code":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-race"}]}]},{"type":"Condition","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"],"mustSupport":["code"],"codeFilter":[{"path":"code","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.369"}]},{"type":"Condition","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"],"mustSupport":["code","severity"],"codeFilter":[{"path":"code","code":[{"system":"http://snomed.info/sct","code":"134401001","display":"Left ventricular systolic dysfunction (disorder)"}]},{"path":"severity","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1092"}]},{"type":"Condition","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"],"mustSupport":["code"],"codeFilter":[{"path":"code","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.403"}]},{"type":"Condition","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"],"mustSupport":["code"],"codeFilter":[{"path":"code","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.366"}]},{"type":"Condition","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"],"mustSupport":["code"],"codeFilter":[{"path":"code","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.362"}]},{"type":"Condition","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"],"mustSupport":["code"],"codeFilter":[{"path":"code","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.412"}]},{"type":"Condition","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"],"mustSupport":["code"],"codeFilter":[{"path":"code","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.370"}]},{"type":"Condition","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"],"mustSupport":["code"],"codeFilter":[{"path":"code","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.367"}]},{"type":"Condition","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"],"mustSupport":["code"],"codeFilter":[{"path":"code","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.368"}]},{"type":"Procedure","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure"],"mustSupport":["code","performed"],"codeFilter":[{"path":"code","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.371"}]},{"type":"Procedure","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure"],"mustSupport":["code","performed"],"codeFilter":[{"path":"code","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.53"}]},{"type":"Observation","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"],"mustSupport":["code","value","status","status.value","effective"],"codeFilter":[{"path":"code","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1134"}]},{"type":"Observation","profile":["http://hl7.org/fhir/StructureDefinition/heartrate"],"mustSupport":["effective","value"]},{"type":"MedicationRequest","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-mednotrequested"],"mustSupport":["medication"],"codeFilter":[{"path":"medication","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1184"}]},{"type":"MedicationRequest","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-mednotrequested"],"mustSupport":["medication"],"codeFilter":[{"path":"medication","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1174"}]},{"type":"Coverage","profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage"],"mustSupport":["type","period"],"codeFilter":[{"path":"type","valueSet":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591"}]}]}],"extension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-populationBasis","valueCode":"boolean"},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-softwaresystem","valueReference":{"reference":"Device/cqf-tooling"}},{"id":"effective-data-requirements","url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-effectiveDataRequirements","valueReference":{"reference":"#effective-data-requirements"}}],"url":"http://ecqi.healthit.gov/ecqms/Measure/EXM145v11QICore4","identifier":[{"use":"official","system":"http://example.org/fhir/cqi/ecqm/Measure/Identifier/exm","value":"145FHIR"},{"use":"official","type":{"coding":[{"system":"http://hl7.org/fhir/us/cqfmeasures/CodeSystem/identifier-type","code":"version-independent"}]},"system":"urn:ietf:rfc:3986","value":"urn:uuid:80744ae2-de81-4b16-a71d-69522eb865c5"},{"use":"official","type":{"coding":[{"system":"http://hl7.org/fhir/us/cqfmeasures/CodeSystem/identifier-type","code":"version-specific"}]},"system":"urn:ietf:rfc:3986","value":"urn:uuid:448dd09b-94e7-434f-8ac8-54883bc90b0c"},{"use":"usual","type":{"coding":[{"system":"http://hl7.org/fhir/us/cqfmeasures/CodeSystem/identifier-type","code":"short-name"}]},"value":"145-QICore"}],"version":"1.0.000","name":"EXM145v11QICore4","title":"Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <=40%) (QICore)","status":"draft","experimental":true,"date":"2023-01-13T09:28:00-06:00","publisher":"American Heart Association","contact":[{"telecom":[{"system":"url","value":"https://www.heart.org"}]}],"description":"Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period who also have a prior MI or a current or prior LVEF &lt;=40% who were prescribed beta-blocker therapy","purpose":"Unknown","copyright":"Copyright 2022 American College of Cardiology and American Heart Association. All Rights Reserved.","effectivePeriod":{"start":"2022-01-01","end":"2022-12-31"},"relatedArtifact":[{"extension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-isPrimaryCitation","valueBoolean":true}],"type":"citation","citation":"Gibbons, R. J., Abrams, J., Chatterjee, K., Daley, J., Deedwania, P.K, Douglas J.S., â€¦ Smith Jr., S.C. (2002). ACC/AHA 2002 Guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1999 guidelines for the management of patients with chronic stable angina). Circulation, 107(1), 149-158.","url":"https://doi.org/10.1161/01.CIR.0000047041.66447.29","document":{"url":"https://doi.org/10.1161/01.CIR.0000047041.66447.29"}}],"library":["http://ecqi.healthit.gov/ecqms/Library/EXM145v11QICore4"],"disclaimer":"The Measure is not a clinical guideline, does not establish a standard of medical care, and has not been tested for all potential applications. \n\nThe Measure, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measure for commercial gain, or incorporation of the Measure into a product or service that is sold, licensed or distributed for commercial gain. \n\nCommercial uses of the Measure require a license agreement between the user and the American College of Cardiology (ACC) or the American Heart Association (AHA). Neither the ACC, nor AHA, nor their members shall be responsible for any use of the Measure.\n\nACC and AHA encourage use of the Measure by other health care professionals, where appropriate.\n\nTHE MEASURE AND SPECIFICATIONS ARE PROVIDED &quot;AS IS&quot; WITHOUT WARRANTY OF ANY KIND.\n\nLimited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The ACC and AHA and their members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT[R]) or other coding contained in the specifications.\n\nCPT(R) contained in the Measure specifications is copyright 2004-2021 American Medical Association. LOINC(R) is copyright 2004-2021 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2021 International Health Terminology Standards Development Organisation. ICD-10 is copyright 2021 World Health Organization. All Rights Reserved.\n\nThe American Medical Associationâ€™s and the PCPI(R) Foundationâ€™s significant past efforts and contributions to the performance measure are gratefully acknowledged.\n\nDue to technical limitations, registered trademarks are indicated by (R) or [R].","scoring":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-scoring","code":"proportion","display":"Proportion"}]},"type":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-type","code":"process"}]}],"rationale":"For patients with coronary artery disease (CAD), beta-blockers are recommended for 3 years after myocardial infarction or acute coronary syndrome. Beta-blockers, particularly carvedilol, metoprolol succinate, or bisoprolol which have been shown to reduce risk of death, are recommended indefinitely for patients with CAD and LV systolic dysfunction. These agents have proven efficacy in reducing angina onset and improving the ischemic threshold during exercise. In patients who have suffered an MI, beta-blockers significantly reduce deaths and recurrent MIs (ACCF/AHA/ACP/AATS/PCNA/SCAI/STS, 2012). \n\nNonadherence to cardioprotective medications is prevalent among outpatients with CAD and can be associated with a broad range of adverse outcomes, including all-cause and cardiovascular mortality, cardiovascular hospitalizations, and the need for revascularization procedures (ACC/AHA, 2002).\n\nThis measure is intended to promote beta-blocker usage in select patients with CAD.","clinicalRecommendationStatement":"Beta-blocker therapy should be started and continued for 3 years in all patients with normal LV function after MI or ACS (Class I, Level of Evidence: B) (ACCF/AHA/ACP/AATS/PCNA/SCAI/STS, 2012).\n\nBeta-blocker therapy should be used in all patients with LV systolic dysfunction (EF &lt;= 40%) with heart failure or prior MI, unless contraindicated. (Use should be limited to carvedilol, metoprolol succinate, or bisoprolol, which have been shown to reduce risk of death.) (Class I, Level of Evidence: A) (ACCF/AHA/ACP/AATS/PCNA/SCAI/STS, 2012).","improvementNotation":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-improvement-notation","code":"increase"}]},"guidance":"Beta-blocker therapy:\n- For patients with prior MI, beta-blocker therapy includes any agent within the beta-blocker drug class. As of 2015, no recommendations or evidence are cited in current stable ischemic heart disease guidelines for preferential use of specific agents\n- For patients with prior LVEF <=40%, beta-blocker therapy includes the following: bisoprolol, carvedilol, or sustained release metoprolol succinate\n\nThe requirement of two or more visits is to establish that the eligible professional or eligible clinician has an existing relationship with the patient.\n\nA range value should satisfy the logic requirement for 'Ejection Fraction' as long as the ranged observation value clearly meets the less than or equal to 40% threshold noted in the denominator logic. A range that is greater than 40% would not meet the measure requirement.\n\nIf a patient has had a myocardial infarction (MI) within the past 3 years and a current or prior LVEF <=40% (or moderate or severe LVSD), the patient should only be counted in Population Criteria 1. \n\nThis eCQM is a patient-based measure.\n\nThis version of the eCQM uses QI-Core v4.1.1. Please refer to the QI-Core Implementation Guide (http://hl7.org/fhir/us/qicore/) for more information on QI-Core.","group":[{"id":"group-1","population":[{"id":"eb8c7e8a-7905-49d1-a34a-b0157a3e6bc2","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"criteria":{"language":"text/cql.identifier","expression":"Initial Population"}},{"id":"c0f6e8b6-c013-43ca-94c9-90ee629790d2","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"criteria":{"language":"text/cql.identifier","expression":"Denominator 1"}},{"id":"afef95c1-f8f5-4d6d-be0f-42df6135b433","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"criteria":{"language":"text/cql.identifier","expression":"Numerator 1"}},{"id":"78f48131-516e-4f9f-a3c8-14bd4ba1132c","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator-exception","display":"Denominator Exception"}]},"criteria":{"language":"text/cql.identifier","expression":"Denominator Exceptions 1"}}]},{"id":"group-2","population":[{"id":"e44d6446-0cc4-41ec-a95f-05a6782f64b5","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"criteria":{"language":"text/cql.identifier","expression":"Initial Population"}},{"id":"e2cd0e48-8381-4f81-be91-b05f10db1046","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"criteria":{"language":"text/cql.identifier","expression":"Denominator 2"}},{"id":"c7dc0310-314d-4085-95e4-1a78ebba10b0","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"criteria":{"language":"text/cql.identifier","expression":"Numerator 2"}},{"id":"f30cd599-c4f1-4341-a09c-75e3c25dffa0","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator-exception","display":"Denominator Exception"}]},"criteria":{"language":"text/cql.identifier","expression":"Denominator Exceptions 2"}}]}],"supplementalData":[{"id":"dfcb0253-8e52-4767-9e44-d2d82968479c","usage":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-data-usage","code":"supplemental-data"}]}],"criteria":{"language":"text/cql.identifier","expression":"SDE Ethnicity"}},{"id":"71c525eb-4d78-4141-82c7-0f76633ae6db","usage":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-data-usage","code":"supplemental-data"}]}],"criteria":{"language":"text/cql.identifier","expression":"SDE Payer"}},{"id":"33bd7d80-aeb5-4cb7-8acb-6931a24f018e","usage":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-data-usage","code":"supplemental-data"}]}],"criteria":{"language":"text/cql.identifier","expression":"SDE Race"}},{"id":"341ce28e-c44b-4b19-a192-a03a75dd0e36","usage":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-data-usage","code":"supplemental-data"}]}],"criteria":{"language":"text/cql.identifier","expression":"SDE Sex"}}]}